International Scholarly Research Notices / 2014 / Article / Tab 2 / Research Article
Antimicrobial Resistance of Salmonella enterica Isolates from Tonsil and Jejunum with Lymph Node Tissues of Slaughtered Swine in Metro Manila, Philippines Table 2 Antibiogram of Salmonella enterica isolates generated through VITEK 2 antimicrobial susceptibility testing.
(a) Isolate Serogroup S. enterica serotypeAntimicrobiala AMP AMC CZ CXM CXM AX FOX CAZ CRO FEP M I M I M I M I M I M I M I M I M I Lt16 B Typhimurium ≤2 S ≤2 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lt21 B Typhimurium ≥32 R ≤2 S ≥64 R ≥64 R ≥64 R ≤4
*R ≤1 S ≤1 S ≤1 S Lt24 B Typhimurium ≥32 R 16 I ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lt30 B Typhimurium ≤2 S ≤2 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lai1 B Agona ≤2 S ≤2 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lai27 B Typhimurium ≤2 S ≤2 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lat23 B Agona ≤2 S ≤2 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lat27 B Agona ≤2 S ≤2 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lbt30 B Typhimurium ≤2 S ≤2 S ≤4
*R ≤1
*R ≤1
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lct47 B Typhimurium ≥32 R 8 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Nt4 B Typhimurium ≥32 R 4 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Pt26 B Heidelberg ≥32 R 4 S ≤4
*R 8
*R 8
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lat20 C1 Choleraesuis ≤2 S ≤2 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lbt18 C1 Choleraesuis ≥32 R 16 I ≥64 R 8
*R 8
*R ≥64* R ≤1 S ≤1 S ≤1 S Lt25 D Enteritidis ≥32 R ≥32 R ≥64 R ≥64 R ≥64 R ≥64 R 4*
*R ≥64 R 2 S Li16 E Weltevreden ≤2 S ≤2 S ≤4
*R ≤1
*R ≤1
*R ≤4
*R ≤1 S ≤1 S ≤1 S Lt3 E Weltevreden ≥32 R 4 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Mbi8 E Weltevreden ≥32 R 4 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S Mbi25 E Weltevreden ≥32 R ≥32 R ≥64 R 16
*R 16
*R 16
*R ≤1 S ≤1 S ≤1 S Pt12 E Weltevreden ≤2 S ≤2 S ≤4
*R 4
*R 4
*R ≤4
*R ≤1 S ≤1 S ≤1 S
AMP: ampicillin; AMC: amoxicillin/clavulanic acid; CZ: cefazolin; CXM: cefuroxime; CXM AX: cefuroxime axetil; FOX: cefoxitin; CAZ: ceftazidime; CRO: ceftriaxone; FEP: cefepime; M: minimum inhibitory concentration (MIC); I: interpretation; *modified by machine (Clinical and Laboratory Standards Institute, 2012 [13 ]).(b) Isolate Serogroup S. enterica serotypeAntimicrobiala ETP IPM MEM AN GM LEV TGC SXT M I M I M I M I M I M I M I M I Lt16 B Typhimurium ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S ≤0.5 S ≤20 S Lt21 B Typhimurium ≤0.5 S 4* S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 2 S ≤20 S Lt24 B Typhimurium ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S ≤0.5 S ≤20 S Lt30 B Typhimurium ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 1 S ≤20 S Lai1 B Agona ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S ≤0.5 S ≤20 S Lai27 B Typhimurium ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 1 S ≤20 S Lat23 B Agona ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S ≤0.5 S ≤20 S Lat27 B Agona ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S ≤0.5 S ≤20 S Lbt30 B Typhimurium ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 4 I ≤20 S Lct47 B Typhimurium ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R 1 S 1 S ≥320 R Nt4 B Typhimurium ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 2 S ≥320 R Pt26 B Heidelberg ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 2 S ≥320 R Lat20 C1 Choleraesuis ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 1 S ≤20 S Lbt18 C1 Choleraesuis ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S ≤0.5 S ≥320 R Lt25 D Enteritidis ≥8 R 4 S 1 S ≤2
*R ≤1
*R 1 S ≥8 R ≥320 R Li16 E Weltevreden ≤0.5 S 4* S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 4 I ≤20 S Lt3 E Weltevreden ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≥16 R ≤0.12 S ≤0.5 S ≤20 S Mbi8 E Weltevreden ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≥16 R ≤0.12 S ≤0.5 S ≥320 R Mbi25 E Weltevreden ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R 1 S 2 S ≤20 S Pt12 E Weltevreden ≤0.5 S ≤1 S ≤0.25 S ≤2
*R ≤1
*R ≤0.12 S 1 S ≤20 S
ETP: ertapenem; IPM: imipenem; MEM: meropenem; AN: amikacin; GM: gentamicin; LEV: levofloxacin; TGC: tigecycline; SXT: trimethoprim/sulfamethoxazole; M: minimum inhibitory concentration (MIC); I: interpretation; *modified by machine (Clinical and Laboratory Standards Institute, 2012 [13 ]).
